Khadem Azarian, Shahin <br/><br/>
Effects of guluronic acid, as a new NSAID with immunomodulatory properties on IL-17, RORγt, IL-4 and GATA-3 gene expression in rheumatoid arthritis patients.  [electronic resource] 

 -  Immunopharmacology and immunotoxicology  Feb 2020 
 - 22-27 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Video-Audio Media 
<br/><br/><label>ISSN: </label>1532-2513 
<br/><br/><label>Standard No.: </label>10.1080/08923973.2019.1702053  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Arthritis, Rheumatoid--drug therapy<br/>Female<br/>GATA3 Transcription Factor--immunology<br/>Gene Expression Regulation--drug effects<br/>Hexuronic Acids--administration & dosage<br/>Humans<br/>Immunologic Factors--administration & dosage<br/>Interleukin-17--immunology<br/>Interleukin-4--immunology<br/>Male<br/>Middle Aged<br/>Nuclear Receptor Subfamily 1, Group F, Member 3--immunology